Medically reviewed by Hemal Patel, PhD, Professor of Anesthesiology at UC San Diego School of Medicine. UCSD profile.
In the UK, people tend to divide healthcare spending into two moral categories. There is what the NHS covers, which feels legitimate. Then there is everything else, which can feel either indulgent or faintly suspect. Preventative testing often lands in the second bucket, even when the underlying question is perfectly sensible: am I heading in the wrong direction before symptoms arrive?
That makes the price question important. At £599, a private testing package is not an impulse purchase. It sits in the zone where people want a clear answer about value rather than vague promises about optimisation. Fair enough.
The honest answer is that £599 can be either worthwhile or entirely unnecessary. It depends less on the packaging, and more on whether the test gives you information that routine care is unlikely to provide, whether the results are interpretable, and whether you are prepared to act on what they show.[1][2]
What you are actually paying for
When people see a headline number, they often compare it with a single NHS blood test, or with a discounted home kit they found online after eleven minutes of optimistic Googling. That is not usually the right comparison. The real comparison is the combined cost of chasing answers in fragments.
A structured private preventative package may include test logistics, sample handling, laboratory analysis, a grouped panel of biomarkers, reporting, and some degree of interpretation. In other words, you are not just buying tubes of blood and a PDF. You are buying organisation and context as well.
That does not mean every private package deserves its price. Some are little more than wellness theatre in a clean font. But it does mean the proper question is whether the bundle produces useful decision-grade information, not whether a single biomarker might be obtainable somewhere else for less.
Where the NHS fits, and where it usually does not
The NHS remains the correct route for diagnosis, symptoms, treatment, emergency care, and risk management at population scale. It is not designed to provide every motivated adult with an expansive, curiosity-driven baseline. That is not a flaw. It is a resource allocation decision.
As we outlined in our guide to preventative tests the NHS does not routinely offer, many useful markers sit outside standard preventive pathways unless there is a specific indication. If you are well, functioning, and merely interested in finding problems early, the system will often prefer watchful pragmatism over extensive measurement.[3]
That leaves a gap. Some people are happy with that gap. Others are not, particularly if they have family history, persistent fatigue, cardiometabolic concerns, high work stress, or a sense that "normal enough" is not quite the same as informed.
When £599 can be reasonable value
Private preventative testing tends to make the most sense for people who have a practical reason to want a clearer baseline. That might include:
- a strong family history of cardiovascular disease, type 2 diabetes, or early decline,
- borderline NHS results that do not quite explain how you feel,
- limited time to assemble multiple private appointments,
- a desire to make lifestyle changes based on data rather than instinct,
- an intention to repeat testing later and track whether anything has genuinely improved.
In those cases, £599 may compare reasonably with the drip-drip cost of ad hoc private GP visits, standalone blood panels, supplement spending, and speculative health purchases that are far easier to buy than to justify. Prevention done badly becomes expensive very quickly. Prevention done with a baseline at least has a chance of becoming disciplined.
How to judge value properly
A sober value judgement usually comes down to four questions.
- Is the panel clinically relevant? Evidence-based testing beats novelty every time.
- Will the report help me interpret the findings? More numbers without context is just administrative anxiety.
- Would I otherwise spend similar money in a more fragmented way? Many people already do.
- Am I prepared to follow through? Testing without behaviour change is a decorative expense.
If the answer to those questions is mostly yes, £599 starts to look less like extravagance and more like a structured private health purchase. If the answer is mostly no, then the wiser decision may be to wait, speak to your GP, or focus on obvious fundamentals first: sleep, weight, blood pressure, movement, alcohol, and diet quality.
Why context matters more than the headline number
One of the better arguments for a platform such as MeScreen is not that it promises magic, but that it frames testing within a broader educational context. Pages such as How MeScreen works, the mitochondrial health overview, and the scientific studies library matter because they help anchor the purchase in explanation rather than mystique.
That is important. In private prevention, the expensive mistake is not necessarily paying for data. It is paying for data that arrives detached from evidence, detached from action, or detached from any honest discussion of limitations. The right buyer should come away clearer, not merely more impressed.
The bottom line
So, is £599 worth it? Sometimes, yes. Not because health spending deserves a halo, and not because instalments make it automatically sensible. It is worth it when the information fills a real gap, is grounded in plausible evidence, and is likely to shape what you do next.
For someone who expects the NHS to cover every preventative question, it may feel unnecessary. For someone already paying privately, short on time, or trying to understand early risk with more precision, it may be entirely defensible.
That is the mildly unspectacular truth. Which, in health, is usually the kind you want.
Medically reviewed by Hemal Patel, PhD
Professor of Anesthesiology at UC San Diego School of Medicine, with research interests in mitochondrial biology, caveolin signalling and cellular bioenergetics.
Read Hemal Patel's MeScreen reviewer profile · Verify on UCSD Profiles
If you are going to pay privately, pay for clarity.
Start with a structured baseline, understand what the data can and cannot tell you, and use it to support decisions rather than decorate them.
Frequently asked questions
Is £599 expensive for a private preventative test in the UK?
It is a meaningful amount of money, so the question is not whether it is cheap, but whether the information is useful enough to change decisions. For some people it is unnecessary. For others, especially those paying privately for fragmented consultations and ad hoc blood work, a structured package can be reasonable value.
Should private preventative testing replace NHS care?
No. NHS care remains the right route for symptoms, diagnosis, treatment and evidence-based management. Private preventative testing is best seen as a supplementary option for people who want broader data than routine screening usually provides.
Who is most likely to get value from paying privately?
Usually people with genuine unanswered questions: a family history of chronic disease, borderline metabolic markers, high work stress, limited time, or a desire for a clearer baseline before making lifestyle changes. It is less useful for people who only want reassurance without intending to act on the results.
References
- National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guideline NG238. 2023 update.
- Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B particles and cardiovascular disease: a narrative review. JAMA Cardiol. 2024;9(3):250-258. doi:10.1001/jamacardio.2023.5403.
- NHS. NHS Health Check. Available at: https://www.nhs.uk/tests-and-treatments/nhs-health-check/
- Public Health England. NHS Health Check programme: priorities for commissioners. 2021.